Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0455 Transporter Info | ||||
Gene Name | SLC6A3 | ||||
Transporter Name | Sodium-dependent dopamine transporter | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HEY1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A3 gene in brain neuroblastoma condition | [1] | ||||
TF Protein Name |
Hairy/enhancer-of-split related with YRPW motif protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human neuroblastoma cells (SH-SY5Y) | |||||
Detailed Description |
Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1) has been reported to repress the transcription of SLC6A3 gene in brain neuroblastoma condition, which leads to a decreased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Transcriptional Phenomenon2 |
Repression of SLC6A3 gene in health condition | [2] | ||||
TF Protein Name |
Hairy/enhancer-of-split related with YRPW motif protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
C57BL/6-129/Sv hybrid mice | |||||
Detailed Description |
Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1) has been reported to repress the transcription of SLC6A3 gene in health condition, which leads to a decreased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A3 gene in melanoma condition | [3] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of SLC6A3 gene in melanoma condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A3 gene in breast cancer condition | [4] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) has been reported to activate the transcription of SLC6A3 gene in breast cancer condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
NR4A2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A3 gene in health condition | [5] | ||||
TF Protein Name |
Nuclear receptor subfamily 4 group A member 2 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Dopamine | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
E12.5 mice | |||||
Detailed Description |
Nuclear receptor subfamily 4 group A member 2 (NR4A2) has been reported to activate the transcription of SLC6A3 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Transcriptional Phenomenon2 |
Activation of SLC6A3 gene in nicotine dependence condition | [6] | ||||
TF Protein Name |
Nuclear receptor subfamily 4 group A member 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Nuclear receptor subfamily 4 group A member 2 (NR4A2) has been reported to activate the transcription of SLC6A3 gene in nicotine dependence condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
PPARD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A3 gene in myofibroblast condition | [7] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor delta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Peroxisome proliferator-activated receptor delta (PPARD) has been reported to repress the transcription of SLC6A3 gene in myofibroblast condition, which leads to a decreased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A3 gene in erythroleukemia condition | [8] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC6A3 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
ZBTB14 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A3 gene in adrenal gland pheochromocytoma condition | [9] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 14 | Transcription Factor Info | ||||
Studied Phenotype |
Adrenal gland pheochromocytoma [ICD11: 2D11.1] | |||||
Tissue |
Adrenal gland | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Rat adrenal gland pheochromocytoma cells (PC12) | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 14 (ZBTB14) has been reported to activate the transcription of SLC6A3 gene in adrenal gland pheochromocytoma condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
OTP |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A3 gene in health condition | [10] | ||||
TF Protein Name |
Homeobox protein orthopedia | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Embryo | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Zebrafish | |||||
Detailed Description |
Homeobox protein orthopedia (OTP) has been reported to activate the transcription of SLC6A3 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
PITX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A3 gene in health condition | [11] | ||||
TF Protein Name |
Pituitary homeobox 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Dopamine | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 Pitx3 KO mice | |||||
Detailed Description |
Pituitary homeobox 3 (PITX3) has been reported to activate the transcription of SLC6A3 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ELF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A3 gene | [12] | ||||
TF Protein Name |
ETS-related transcription factor Elf-1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS-related transcription factor Elf-1 (ELF1) has been reported to bind to the transcription of SLC6A3 gene in . condition, which leads to a affected expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A3 gene in health condition | [13] | ||||
TF Protein Name |
Signal transducer and activator of transcription 6 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Sata6 KO mice | |||||
Detailed Description |
Signal transducer and activator of transcription 6 (STAT6) has been reported to activate the transcription of SLC6A3 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A3 gene in health condition | [14] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC6A3 gene in health condition, which leads to a affected expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A3 gene in prostate cancer condition | [15] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC6A3 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.